Wednesday, April 17, 2013
BioCryst Flu Drug Moves Closer to FDA Filing
BioCryst’si
nfluenza treatment Peramivir is a step closer to a filing with the Food and Drug Administration after a meeting with the government agency.
No comments:
Post a Comment
Newer Post
Older Post
Home
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment